Gene: SPINT1
Official Full Name: serine peptidase inhibitor, Kunitz type 1provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the Kunitz family of serine protease inhibitors. The protein is a potent inhibitor specific for HGF activator and is thought to be involved in the regulation of the proteolytic activation of HGF in injured tissues. Alternative splicing results in multiple variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35265 | SPINT1 Knockout cell line (HeLa) | Human | SPINT1 | 1:3~1:6 | Negative | Online Inquiry |
KO35266 | SPINT1 Knockout cell line (HCT 116) | Human | SPINT1 | 1:2~1:4 | Negative | Online Inquiry |
KO35267 | SPINT1 Knockout cell line (HEK293) | Human | SPINT1 | 1:3~1:6 | Negative | Online Inquiry |
KO35268 | SPINT1 Knockout cell line (A549) | Human | SPINT1 | 1:3~1:4 | Negative | Online Inquiry |
SPINT1 Gene Knockout Cell Lines are genetically engineered cell models lacking the SPINT1 gene, which plays a critical role in regulating protease activity and maintaining cellular homeostasis. By utilizing CRISPR-Cas9 technology, these cell lines are precisely modified to exhibit a knockout of the SPINT1 gene, thereby allowing researchers to study the downstream effects of SPINT1 loss in various biological processes.
The primary function of SPINT1, an inhibitor of serine proteases, is vital for modulating cell signaling pathways and maintaining extracellular matrix stability. By employing SPINT1 Gene Knockout Cell Lines in research, scientists can elucidate the pathophysiological consequences of SPINT1 deficiency, including its potential implications in cancer metastasis, fibrosis, and inflammatory diseases. The knockout models facilitate investigations into the molecular mechanisms that govern these processes, providing insights that can lead to novel therapeutic targets.
The scientific importance of these cell lines extends to both basic and applied research settings. Researchers can utilize SPINT1 knockout lines for drug discovery and Western blotting studies, thereby advancing the understanding of protease-related pathways in disease states. Furthermore, the versatility of these cell lines allows for their application in diverse experimental conditions, including 3D cultures and co-culture systems.
Compared to conventional models, SPINT1 Gene Knockout Cell Lines offer unique advantages, such as a reproducible genetic background, consistent phenotype expression, and ease of integration into high-throughput screening platforms. This reliability is crucial for generating robust data that can enhance the translation of findings from bench to bedside.
For researchers and clinicians alike, the SPINT1 Gene Knockout Cell Lines represent a valuable tool that can accelerate the progression of scientific inquiry and therapeutic development. With a focus on innovation and excellence, our company is committed to offering high-quality biological products that empower the scientific community to unlock the complexities of gene function and disease mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.